Wantao Wu
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Correction to: Single‑cell analysis identified PDIA3 as regulator of malignant characteristics and macrophage function in human cancers.
Journal: Functional & integrative genomics
Published: September 02, 2024
Single-cell analysis identified PDIA3 as regulator of malignant characteristics and macrophage function in human cancers.
Journal: Functional & integrative genomics
Published: June 22, 2024
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response.
Journal: Cancer communications (London, England)
Published: January 18, 2024
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC.
Journal: Hepatology (Baltimore, Md.)
Published: September 30, 2023
Causal relationship and shared genes between air pollutants and amyotrophic lateral sclerosis: A large-scale genetic analysis.
Journal: CNS neuroscience & therapeutics
Published: July 23, 2023
The causal effect of air pollution on the risk of essential hypertension: a Mendelian randomization study.
Journal: Frontiers in public health
Published: June 25, 2023
The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma.
Journal: Heliyon
Published: June 20, 2023
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Journal: Molecular cancer
Published: June 19, 2023
Patient-derived xenograft models in cancer therapy: technologies and applications.
Journal: Signal transduction and targeted therapy
Published: December 22, 2022
A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer.
Journal: iScience
Published: November 28, 2022
An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms.
Journal: Cell proliferation
Published: November 10, 2022
Last Updated: 09/26/2026